13G Filing: Armistice Capital and Histogenics Corp (HSGX)

Page 5 of 9 – SEC Filing

CUSIP No
43358V109
Item 1.
(a).
Name of Issuer:
Histogenics Corporation
(b).
Address of Issuer’s Principal Executive Offices:
830 Winter Street, 3rd Floor
Waltham, Massachusetts  02451
United States of America
Item 2.
(a).
Name of Person Filing:
Armistice Capital, LLC
Armistice Capital Master Fund Ltd.
Steven Boyd
(b).
Address of Principal Business Office, or if None, Residence:
Armistice Capital, LLC
510 Madison Avenue, 22nd Floor
New York, New York 10022
United States of America
Armistice Capital Master Fund Ltd.
c/o dms Corporate Services Ltd.
20 Genesis Close
P.O. Box 314
Grand Cayman KY1-1104
Cayman Islands
Steven Boyd
c/o Armistice Capital, LLC
510 Madison Avenue, 22nd Floor
New York, New York 10022
United States of America
(c)
Citizenship:
Armistice Capital, LLC – Delaware
Armistice Capital Master Fund Ltd. – Cayman Islands
Steven Boyd – United States of America
(d).
Title of Class of Securities:
Common Stock, $0.01 par value per share
(e).
CUSIP Number:
43358V109

Follow Ocugen Inc. (NASDAQ:OCGN)